Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome-Reference-Cited by-同舟云学术

Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome

Published:2020-06-04 Issue:2 Volume:52 Page:351-358
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Moore Kevin¹,Jamil Khurram²,Verleger Katharina³,Luo Linlin⁴,Kebede Nehemiah⁴,Heisen Marieke⁵,Corman Shelby⁴^ORCID,Leonardi Roberta¹,Bakker Rachel⁵,Maï Christine⁶,Shamseddine Nisreen²,Huang Xingyue²,Allegretti Andrew S.⁷

Affiliation:

1. UCL Institute of Liver and Digestive Health; Royal Free Hospital; University College London; London UK

2. Mallinckrodt Pharmaceuticals; Bedminster NJ USA

3. Pharmerit International; Berlin Germany

4. Pharmerit International; Bethesda MD USA

5. Pharmerit International; Rotterdam The Netherlands

6. AplusA; Lyon France

7. Division of Nephrology; Department of Medicine; Massachusetts General Hospital; Boston MA USA

Funder

Mallinckrodt Pharmaceuticals

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15836/fullpdf

Reference24 articles.

1. Hepatorenal syndrome in hospitalized patients with chronic liver disease: results from the Nationwide Inpatient Sample 2002-2012;Pant;J Investig Med,2016

2. Acute kidney injury in cirrhosis;Garcia-Tsao;Hepatology,2008

3. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis;European Association for the Study of the Liver;J Hepatol,2018

4. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites;Angeli;J Hepatol,2015

5. Prognostic importance of the cause of renal failure in patients with cirrhosis;Martín-Llahí;Gastroenterology,2011

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Mortality Rates of Vasoconstrictor Agents in the Management of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis;Cureus;2024-08-16

2. Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting;Journal of Hepatology;2024-07

3. Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: PRO;Kidney360;2024-06

4. Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: CON;Kidney360;2024-06

5. Controversies in terlipressin and transplantation in the United States: How do we MELD the two?;Liver Transplantation;2024-03-28